Rocket,
“accelerate to clinical studies"
Was something that caught my attention with this stock 10 years ago.
It still can’t hold a sp equal of the 3c I paid for way back then.
I don’t know of any other company on the ASX that’s had the same CEO for ten years that has delivered zero value to shareholders
